Skip to main content

Navigation principale

About
Team
Portfolio
Strategy
ESG
Testimonials
News
Contact

Secondary Navigation

Fr
En

ATB Therapeutics

Back to companies

Company name

ATB Therapeutics

Investment amount

5 M€

Location

Marche-en-Famenne
Belgium

Investment date

18/11/2024

CEO

Bertrand Magy

Website

VIVES Funds

VIVES Partners
Chemin du Stocquoy, 1
1300 Wavre
Belgium

Email

info@vivesfund.com

GSM

+32 472 206 355

Contact

Your Name

Prénom

Your Email

Téléphone

Origin

Please note that VIVES only invests in companies located in Europe.

Message

Documents

Maximum 5 files.
256 MB limit.
Allowed types: txt, rtf, pdf, doc, docx, odt, ppt, pptx, odp, xls, xlsx, ods.

Merci de me contacter

J’ai lu et j’accepte la politique générale de protection des données personnelles.

Lire la politique générale de protection des données personnelles.

VIVES is a multi-sector technology fund that invests in spin-offs from UCLouvain and start-ups in Belgium and neighboring countries. The fund has the ability to invest at different stages of a company's development: seed, start-up and growth.

Menu Pied de page

Privacy policy & cookies
Terms & conditions

Website by Visible